Isis Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
118.99 Mil |
| Income |
-15.88 Mil |
| Net Profit Margin |
-17.19% |
| Return on Equity |
-8.79% |
| Debt/Equity Ratio |
0.48 |
|
| Revenue/Share |
1.18 |
| Earnings/Share |
1.38 |
| Book Value/Share |
2.98 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 31.6 | 18.4 | 2.5 |
| 2nd Qtr | 31.0 | 29.7 | 3.8 |
| 3rd Qtr | 26.8 | 29.5 | 38.6 |
| 4th Qtr | NA | 29.6 | 21.6 |
| Total | 89.3 | 107.2 | 66.4 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $1.76 | -$0.06 | -$0.16 |
| 2nd Qtr | -$0.03 | -$0.04 | -$0.13 |
| 3rd Qtr | -$0.07 | $0.02 | -$1.25 |
| 4th Qtr | NA | -$0.09 | -$0.08 |
| Total | $1.66 | -$0.17 | -$1.62 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | NA | 25% | --- |
| 2nd Qtr | NA | 33% | 19% |
| 3rd Qtr | -133% | NA | -862% |
| 4th Qtr | NA | NA | 94% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | NA | 63% |
| 2nd Qtr | 25% | 69% |
| 3rd Qtr | NA | NA |
| 4th Qtr | NA | -13% |
advertisement
Recent News